Skip to Main Content

Paper Details

Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Nat Commun
67
2017
IGF2BP2, KIAA1551, MAFTRR, MGMT, RAD17, USP44, cancer, cancers, candidate, fragile sites, genomic regions, homozygous deletions, human, primary tumours, tumour, tumour suppressor genes, tumour suppressors
Author NameAffiliation
Jonas DemeulemeesterThe Francis Crick Institute
Jonas DemeulemeesterUniversity of Leuven
David C WedgeWellcome Trust Sanger Institute
David C WedgeBig Data Institute, University of Oxford
Hans Kristian Moen VollanInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Hans Kristian Moen VollanThe Francis Crick Institute
Kevin P WhiteInstitute for Genomics and Systems Biology, University of Chicago
Kevin P WhiteInc.
Kevin P WhiteUniversity of Chicago
Kevin P WhiteUniversity of Chicago
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Peter J CampbellWellcome Trust Sanger Institute
Vessela N KristensenInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Michael R StrattonWellcome Trust Sanger Institute
Ole Christian Lingj??rdeUniversity of Oslo
Yves MoreauUniversity of Leuven
Yves MoreauUniversity of Leuven
Peter Van LooThe Francis Crick Institute
Peter Van LooUniversity of Leuven
  • 1 - 20

Datasets

Release 1.2